Enable JavaScript to visit this website.
Skip directly to content

CUA and Pfizer Canada Award One Clinical Fellowship in Incontinence and Three Recipients of the CUA-Pfizer Urology Resident Grant Program


Researcher Dr. Patrick McGarry is the recipient of 2017 fellowship program

The 2017 Canadian Urological Association and Pfizer Canada Clinical Fellowship in Incontinence has been awarded to a Canadian urologist who has just completed his urology residency; Patrick McGarry will be completing his fellowship at Western University, Division of Urology.  With this funding, he will conduct new projects in functional urology to improve support, education and treatment for patients with incontinence.

How do people living with a spinal cord injury select a bladder management method?

Western University (Division of Urology) researcher Dr. Patrick McGarry has been awarded a grant for a project that focuses on quantifying the relative preferences and risk tolerance associated with different bladder management strategies among people with Spinal Cord Injury (SCI). Additionally, the work will be incorporated into a computerized decision aid therefore allowing the patient to be aware of the possible methods for managing their bladder and to be involved in the changes to their treatment regimen.  “With this project, I can truly empower the patients and have them take ownership of their bladder management strategy,” said Dr. McGarry. “This research has the potential to change the way physicians counsel patients about bladder management.”

CUA-Pfizer Urology Resident Grant Program 2017 Winners

The CUA and Pfizer Canada has also recognized three residents for their outstanding research or care enhancement projects that promote excellence in urology with the ultimate goal of improving patient care or further understanding the biology of urologic diseases.




Dr. Alaina Garbens

The health care expenditures and practice patterns in the management of Urethral Stricture Disease in Ontario

University of Toronto


Dr. Jennifer Ann Locke

Cortical Responses to Visual Triggers in Urgency Urinary Incontinence Demonstrated Through Functional Magnetic Resonance Imaging

UBC Department of Urological Sciences - Vancouver

Dr. Rano Matta

Incident dementia in an elderly population with overactive bladder using anticholinergic medications

University of Toronto


About the CUA - Pfizer Canada Clinical Fellowship in Incontinence

The CUA-Pfizer Incontinence Fellowship Award provides much needed funding to support Canadian urologists that have completed their RCPSC training successfully and are embarking on clinical fellowships. The financial support for these fellowships will result in many of the brightest young urologists in Canada furthering their training in centres of excellence around the world in the area of functional urology and bringing their advanced skill and knowledge set back to Canada. This will ultimately result in Canadians receiving the most comprehensive, innovative and contemporary care in incontinence.

“Urological disorders are a growing burden in Canada. These awarded projects and the grant program demonstrate a shared commitment by the CUA and Pfizer to ensure scientific discovery and innovation in the field of urology and specifically, incontinence,” says Dr. Jonathan Izawa, Chair of the Scientific Council of the Canadian Urological Association Scholarship Foundation (CUASF).

“Incontinence has an enormous impact on the quality of life of patients and can significantly alter their social interactions and increase their feeling of helplessness,” says Dr. Vratislav Hadrava, Chief Medical Officer, Pfizer Canada. “Pfizer is proud to support Canadian urological researchers whose work contributes to improving the day-to-day lives of people living with urinary incontinence.”

A sixth year with new fellowships will take place in 2018-2019. For more information on how to apply for 2018 grants, eligible research proposals, review criteria, notification dates and submission process please visit: http://www.cua.org/en/training-scholarships.

About the CUA-Pfizer Urology Resident Grant Program

The CUA-Pfizer Urology Resident Grant Program is meant to support peer-reviewed competitive resident research or care enhancement projects that promote excellence in functional urology with the ultimate goal of improving patient care or further understanding the biology of urologic diseases. The financial support to Canadian urology residents may have great impact by allowing them to test novel hypotheses that established urologists might not have already considered.

About Canadian Urological Association

The Canadian Urological Association is a national member-based organization dedicated to enabling the profession to provide the highest possible standards of urologic care by collaboratively:

  • Fostering excellence in urologic practice through advocacy, education, research and practice support tools
  • Leading evidence-based clinical practice through the development of practice standards and guidelines
  • Providing continuous professional development for Canadian urologists along the career-path continuum
  • Providing leadership in public education for urologic conditions
  • Representing the Canadian urologic community in relationships with governments as well as national and international medical societies.

About Pfizer Canada

Pfizer Canada is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines, infusion systems and vaccines. Pfizer’s ongoing research and development activities focus on a wide range of therapeutic areas following our guiding aspiration: Working together for a healthier world. To learn more about Pfizer Canada, visit pfizer.ca or you can follow us on Twitter (twitter.com/PfizerCA) or Facebook (facebook.com/Pfizer.Canada).

For further information:

For more information, please contact:
Pfizer Canada Media Line: 1-866-9Pfizer (1 866 973-4937)
[email protected]